The change of β-adrenergic system in lead-induced hypertension

Toxicology and Applied Pharmacology

Volumn 164, Issue 2, 2000, Pages 127-133

  Tsao, Der An ^b   Yu, Hsin Su ^a   Cheng, Juei Tang ^b   Ho, Chi Kung ^a   Chang, Huoy Rou ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NONE

Author keywords

Cyclic AMP; Hypertension; Lead; adrenoceptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYANOPINDOLOL I 125; CYCLIC AMP; LEAD ACETATE;

ABSORPTION SPECTROSCOPY; ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HYPERTENSION; LEAD POISONING; NONHUMAN; RADIOIMMUNOASSAY; RAT; RISK FACTOR;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0034656205     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8871     Document Type: Article

References (42)

1. Beierwaltes W. H., Schryver S., Olson P. S., Romero J. C. Control of renin release in isolated rat glomerule. Hypertension. 3:1981;11-30.
2. Bensard D. D., Banerjee A., McIntyre R. C., Berens R. L., Harken A. H. Endotoxin disrupts β-adrenergic signal transduction in the heart. Arch. Surg. 129:1994;198-205.
3. Bertel O., Buhler F. R., Kiowski W., Lutold B. E. Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 2:1980;130-138.
4. Bertel O., Buhler F. R., Ott J. Lead-induced hypertension: Blunted beta-adrenoceptor-mediated functions. Br. Med. J. 4:1978;551.
5. 2-adrenergic receptors and plasma catecholamine levels in lead-exposed workers. Toxicol. Appl. Pharmacol. 138:1996;1-5.
6. 2-adrenergic receptors in salt-related and genetic hypertension. Pharmacology. 34:1987;131-142.
7. Doyle A. E., Fraser R. E. Vascular reactivity in hypertension. Circ. Res. 9:1961;755-758.
8. Eisinger J., Blumberg W. E., Fischbein A. A., Lilis R., Selikoff I. J. Zinc protoporphyrin in blood as a biological indicator of chronic lead intoxication. Environ. Pathol. Toxicol. 1:1978;897-910.
9. Fleischer N., Mouw D. R., Vander A. J. Chronic effects of lead on renin and renal sodium excretion. J. Lab. Clin. Med. 95:1980;759-770.
10. Freissmuth M., Kraupp O., Hausleithner V., Tuisl E., Schutz W. Alterations of glomerular β-adrenoceptor-linked adenylate cyclase system in perinephritis hypertension. J. Cardiovasc. Pharmacol. 8:1986;60-66.
11. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 84:1987;7920-7924.
12. Goldstein D. S., Feuerstein C., Izzo J. L., Kopin I. J. Jr., Keiser H. R. Current Concepts: II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life. Sci. 28:1981;467-475.
13. Grandjean P., Lintrup J. Erythrocyte-Zn-Protoporphyrin as an indicator of lead exposure. Scand. J. Clin. Lab. Invest. 38:1978;669-675.
14. Guyton A. C. Blood pressure control: Special role of the kidneys and body fluids. Science. 252:1991;1813-1816.
15. Kaumann A. J. Is there a third heart β-adrenoceptor. Trends Pharmacol. Sci. 10:1989;316.
16. Keeton T. K., Campbell W. B. The pharmacological alteration of renin release. Pharmacol. Rev. 32:1981;81-227.
17. 2-adrenergic receptor: A protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 84:1987;46-50.
18. Lamola A. A., Joselow M., Yamane T. Zinc protoporphyrin. (ZPP). A simple, sensitive fluorometric screening test for lead poisoning. Clin. Chem. 21:1975;93.
19. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Maheswaran R., Gill J. S., Beevers D. G. Blood pressure and industrial lead exposure. Am. J. Epidemiol. 137:1993;645-653.
21. McAllister R. G., Michelakis A. M., Sandstead H. H. Plasma renin activity in chronic plumbism. Arch. Intern. Med. 127:1971;919-923.
22. Mendlowitz M. Vascular reactivity in systemic arterial hypertension. Am. Heart J. 85:1973;252-259.
23. Michel M. C., Brodde O-E., Insel P. A. Peripheral adrenergic receptors in hypertension. Hypertension. 16:1990;107-120.
24. 2-adrenoceptors in rat models of acquired hypertension. J. Cardiovasc. Pharmacol. 13:1989;421-431.
25. Michel M. C., Siegl H., Larson D. F., Arkstein R., Khamssi M., Brodde O-E. Effects of cyclosporin A on blood pressure and beta-adrenoceptor density in spontaneously hypertensive rats. J. Hypertens. 5:1987a;S125-S127.
26. Michel M. C., Siepmann F., Buscher R., Philipp T., Brodde O-E. Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. Hypertension. 22:1993;169-177.
27. 2-adrenoceptor density in heart, lung and kidney of spontaneously hypertensive rats. J. Auton. Pharmacol. 7:1987b;41-51.
28. Moller L., Kristensen T. S. Blood lead as a cardiovascular risk factor. Am. J. Epidemiol. 136:1992;1091-1100.
29. Murata K., Araki S. Autonomic nervous system dysfunction in works exposed to lead, zinc, and copper in relation to peripheral nerve conduction: A study of R-R interval variability. Am. J. Ind. Med. 20:1991;663-671.
30. Nowack R., Wiecek A., Ritz E. Lead and hypertension. Contrib. Nephrol. 100:1992;25-34.
31. Prentice R. C., Kopp S. J. Cardiotoxicity of lead at various perfusate calcium concentrations: Functional and metabolic responses of the perfused rat heart. Toxicol. Appl. Pharmacol. 81:1985;491-501.
32. Scatchard G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:1949;660-672.
33. Shukla A., Agarwai K. N., Shukla G. S. Effect of latent iron deficiency on the levels of iron, calcium, zinc, copper, manganese, cadmium and lead in liver, kidney and spleen of growing rats. Experientia. 46:1990;751-752.
34. Snavely M. D., Ziegler M. G., Insel P. A. Subtype-selective down-regulation of rat renal cortical α- and β-adrenergic receptors by catecholamines. Endocrinology. 117:1985;2182-2189.
35. Struyker-Boudier H. A. J., Vervoort-Peters L. H. T. M., Rousch M. J. M., Smits J. F. M., Thijssen H. H. W. Beta-adrenoceptors in kidney tubules of spontaneously hypertensive and normotensive rats. Life Sci. 38:1986;137-145.
36. Suga R. S., Fischinger A. J., Knoch F. W. Establishment of normal values in adults for zinc protoporphyrin (ZPP) using hematofluorometer: Correlation with normal blood lead values. Am. Ind. Hyg. Assoc. J. 42:1981;637-642.
37. Tsujimoto G., Lee C-H., Hoffman B. B. Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J. Pharmacol. Exp. Ther. 239:1986;411-415.
38. Wang Y. L., Lu P. K., Chen Z. Q. Effects of occupational lead exposure. Scand. J. Work Environ. Health. 11:1985;20-25.
39. Wildt K., Berlin M., Isberg P. E. Monitoring of zinc protoporphyrin levels in blood following occupational lead exposure. Am. J. Ind. Med. 12:1987;385-398.
40. Wilke, L. 1987, Early and late effects of neonatal lead exposure or in vitro renin release. Thorofare (NJ), American Society of Nephrology, Thorofare, NJ. [abstract].
41. Woodcock E. A., Johnston C. I. Changes in tissue alpha- and beta-adrenergic receptors in renal hypertension in the rat. Hypertension. 2:1980;156-161.
42. Yamada S., Nakamoto M., Hayashi M., Tomita T., Hayashi E. Tubular and glomerular adrenoceptors in stroke-prone spontaneously hypertensive rats. J. Hypertens. 4:1986;S209-S211.